Neuroinvasiveness of SARS-CoV-2 shown by viral RNA and inflammation in the brain The coronavirus disease 2019 (COVID-19) pandemic has claimed well over 2.4 million lives, but its long-term sequelae are still being identified. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces an infection that may be associated with a wide spectrum of disease, from asymptomatic to critical or terminal respiratory failure or multi-organ dysfunction. A new preprint on the bioRxiv* server describes the results of a macaque study that showed the development of neurological features of inflammation, following infection by SARS-CoV-2. Neurological symptoms in SARS-CoV-2 infection SARS-CoV-2 primarily affects the respiratory organs, but in about a third of hospitalized COVID-19 patients, neurological manifestations are present. These include anosmia or dysgeusia, delirium, impaired consciousness, seizures, or psychosis. Some patients also develop Parkinsonism.